ARCA biopharma to Implement 1-For-12 Reverse Stock Split
ARCA biopharma (ABIO) said Friday its board approved a 1-for-12 reverse stock split of its shares.
The shares will start trading on a split-adjusted basis on Sept. 3 under the new name, Oruka Therapeutics, and under the new symbol "ORKA" following the expected closing of its merger with Oruka, the firm said.
Price: 4.3400, Change: +0.18, Percent Change: +4.33
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。